TGA Urges Sponsors to Focus on Data Integrity, Scraps 15-Day Clearance

Drug GMP Report
A A
Australia’s drug regulatory agency is urging drugmakers to reassess their quality control and data management systems after agency officials found frequent data integrity violations during GMP inspections over the past five years.

To View This Article:

Login

Subscribe To Drug GMP Report